This was announced by Igor Pogrebnyakov, a doctor for X-ray endovascular diagnostics and treatment of the Department of X-ray Surgical Methods of Diagnosis and Treatment of the Department of Interventional Radiology of the Research Institute of Clinical and Experimental Radiology of the N. N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia.

"The drug can be used in the treatment of patients with various types of tumors of the gastrointestinal tract, bile ducts, genitourinary system, upper respiratory tract and skin," RIA Novosti reports the words of the doctor.

The specialist added that the drug has a number of analogues, the experience of which was taken into account during development. According to Pogrebnyakov, the drug is well tolerated and has no serious side effects. However, a contraindication to its use is porphyrin disease.

Earlier it was reported that scientists from Russia have created AI to identify brain tumors.